Sonoma Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,152
Closed -$599K 82
2024
Q3
$599K Sell
1,152
-10
-0.9% -$5.34K 0.93% 35
2024
Q2
$630K Sell
1,162
-19
-2% -$10K 1.02% 34
2024
Q1
$612K Buy
1,181
+71
+6% +$35.3K 0.99% 38
2023
Q4
$523K Buy
1,110
+308
+38% +$142K 0.87% 42
2023
Q3
$349K Buy
802
+84
+12% +$38.1K 0.64% 55
2023
Q2
$319K Buy
+718
New +$331K 0.56% 58

Other funds holding ELV

Sonoma Private Wealth's ELV Position: Q4 2024 in Review

Sonoma Private Wealth sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,152 shares — an estimated $599K sold.

Sonoma Private Wealth first reported a position in ELV in Q2 2023 and held it in 6 quarters. The position peaked at $630K in Q2 2024. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Sonoma Private Wealth reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Sonoma Private Wealth sold 1,152 Elevance Health shares in Q4 2024, an estimated $599K.
  • Sonoma Private Wealth first reported a position in Elevance Health in Q2 2023 and held it in 6 quarters.
  • Sonoma Private Wealth's Elevance Health position peaked at $630K in Q2 2024.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Sonoma Private Wealth's 13F filing for Q4 2024, filed 6 Feb 2025.